Lucipral

Sobre este medicamento

Originator: Gavreto by BLUEPRINT MEDICINES · Manufacturer: Lucius Pharma. Indication & Dosage: Lucipral (Pralsetinib), generic Gavreto, is a prescription medicine used of adult patients diagnosed with metastatic rearranged during transfection (RET) fusion-positive non-small cell lung cancer as detected by an FDA approved test (NSCLC). Pralsetinib is indicated for both adult and pediatric patients aged 12 years and older who have advanced or metastatic RET-mutant medullary thyroid cancer (MTC) and require systemic therapy. Pralsetinib is prescribed for adult and pediatric patients aged 12 years and older with advanced or metastatic RET fusion-positive thyroid cancer who are in need of systemic therapy and are refractory to radioactive iodine treatment. Lucipral manufactured by Lucius Pharma Ltd. In Laos. Pralsetinib has to take orally once daily do not eat food as directed by your patients doctor. Side Effects: The most common side effects of Pralsetinib are: Tiredness , constipation or diarrhea , muscle/joint pain, fever, or swelling in the hands/legs/face. The above information comes from the Internet. Please consult with doctor for medical advice.

Esta información es solo de referencia y no constituye consejo médico. Consulte siempre a un profesional de la salud calificado.